Jones Financial Companies Lllp raised its stake in shares of JPMorgan Chase & Co. (NYSE:JPM) by 3.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 143,127 shares of the financial services provider’s stock after purchasing an additional 5,236 shares during the quarter. Jones Financial Companies Lllp’s holdings in JPMorgan Chase & Co. were worth $14,957,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also modified their holdings of the company. Karpas Strategies LLC increased its stake in shares of JPMorgan Chase & Co. by 0.4% in the 3rd quarter. Karpas Strategies LLC now owns 21,537 shares of the financial services provider’s stock valued at $2,251,000 after acquiring an additional 80 shares during the last quarter. Strategic Family Wealth Counselors L.L.C. increased its stake in JPMorgan Chase & Co. by 3.3% in the second quarter. Strategic Family Wealth Counselors L.L.C. now owns 2,685 shares of the financial services provider’s stock valued at $302,000 after purchasing an additional 85 shares in the last quarter. Keb Asset Management LLC raised its holdings in JPMorgan Chase & Co. by 2.5% in the third quarter. Keb Asset Management LLC now owns 3,485 shares of the financial services provider’s stock worth $364,000 after purchasing an additional 85 shares during the period. Royal Capital Wealth Management LLC boosted its position in shares of JPMorgan Chase & Co. by 0.4% during the second quarter. Royal Capital Wealth Management LLC now owns 19,759 shares of the financial services provider’s stock worth $2,225,000 after purchasing an additional 87 shares in the last quarter. Finally, Altus Wealth Group LLC raised its stake in JPMorgan Chase & Co. by 1.4% during the 2nd quarter. Altus Wealth Group LLC now owns 6,281 shares of the financial services provider’s stock worth $1,028,000 after buying an additional 88 shares during the period. 67.89% of the stock is owned by institutional investors and hedge funds.
JPMorgan Chase & Co. Stock Performance
JPM opened at $138.45 on Wednesday. The business’s 50-day simple moving average is $134.78 and its 200 day simple moving average is $123.13. JPMorgan Chase & Co. has a 52-week low of $101.28 and a 52-week high of $159.03. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.84 and a current ratio of 0.84. The firm has a market capitalization of $406.10 billion, a PE ratio of 11.46, a PEG ratio of 2.10 and a beta of 1.13.
JPMorgan Chase & Co. Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, January 31st. Shareholders of record on Friday, January 6th will be paid a $1.00 dividend. This represents a $4.00 dividend on an annualized basis and a yield of 2.89%. The ex-dividend date is Thursday, January 5th. JPMorgan Chase & Co.’s dividend payout ratio is currently 33.11%.
Insider Activity
In other news, CEO Mary E. Erdoes sold 10,340 shares of the company’s stock in a transaction dated Tuesday, January 17th. The shares were sold at an average price of $140.29, for a total value of $1,450,598.60. Following the sale, the chief executive officer now directly owns 544,136 shares of the company’s stock, valued at approximately $76,336,839.44. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other JPMorgan Chase & Co. news, CEO Mary E. Erdoes sold 10,340 shares of the business’s stock in a transaction that occurred on Tuesday, January 17th. The stock was sold at an average price of $140.29, for a total transaction of $1,450,598.60. Following the transaction, the chief executive officer now owns 544,136 shares of the company’s stock, valued at $76,336,839.44. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director Mellody L. Hobson acquired 375 shares of the company’s stock in a transaction on Thursday, January 19th. The stock was acquired at an average price of $134.53 per share, for a total transaction of $50,448.75. Following the purchase, the director now directly owns 22,040 shares of the company’s stock, valued at $2,965,041.20. The disclosure for this purchase can be found here. Insiders sold a total of 37,887 shares of company stock valued at $5,315,762 in the last quarter. Company insiders own 0.79% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research firms have issued reports on JPM. Royal Bank of Canada set a $130.00 target price on JPMorgan Chase & Co. in a research note on Friday, January 13th. Credit Suisse Group set a $155.00 target price on JPMorgan Chase & Co. in a research note on Tuesday, January 17th. StockNews.com assumed coverage on shares of JPMorgan Chase & Co. in a research note on Wednesday, October 12th. They issued a “hold” rating on the stock. Piper Sandler increased their price objective on shares of JPMorgan Chase & Co. from $150.00 to $157.00 in a research report on Tuesday, January 17th. Finally, Deutsche Bank Aktiengesellschaft cut shares of JPMorgan Chase & Co. from a “buy” rating to a “hold” rating and cut their price objective for the company from $155.00 to $145.00 in a research report on Friday, January 6th. Seven analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. Based on data from MarketBeat.com, JPMorgan Chase & Co. presently has an average rating of “Moderate Buy” and an average price target of $147.89.
JPMorgan Chase & Co. Company Profile
JPMorgan Chase & Co is a financial holding company. It provides financial and investment banking services. The firm offers a range of investment banking products and services in all capital markets, including advising on corporate strategy and structure, capital raising in equity and debt markets, risk management, market making in cash securities and derivative instruments, and brokerage and research.
Featured Stories
- Get a free copy of the StockNews.com research report on JPMorgan Chase & Co. (JPM)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- 3 Retail Stocks Ringing the Register in 2023
Want to see what other hedge funds are holding JPM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for JPMorgan Chase & Co. (NYSE:JPM – Get Rating).
Receive News & Ratings for JPMorgan Chase & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JPMorgan Chase & Co. and related companies with MarketBeat.com's FREE daily email newsletter.